One of the biggest challenges in dermatology is distinguishing between conditions that appear similar. Rashes, plaques, and erythematous lesions can arise from dozens of causes, ranging from mild allergies to severe autoimmune disorders.
The initial working diagnoses included:
-
Contact dermatitis
-
Lupus erythematosus
-
Hives
Further investigation revealed the real culprit:
-
Blood tests ruled out common infections and autoimmune markers.
-
The new inhaler was immediately discontinued.
-
A skin biopsy was performed and pathology confirmed Sweet’s syndrome .
Treatment with oral corticosteroids was initiated, which resulted in a
A dramatic improvement in two days. The plaques disappeared, the fever subsided, and the pain decreased rapidly. What exactly is candy syndrome?
Sweet’s syndrome, or acute febrile neutrophilic dermatosis , is a rare immune-mediated skin condition, first described in 1964 by Dr. Robert Sweet. It is characterized by:
-
Sudden, painful red or purple plaques or papules
-
The injuries were concentrated on the face, neck, torso, and hands.
-
It is accompanied by fever, fatigue, and joint pain.
-
Elevated white blood cell count, especially neutrophils
Known triggers
The exact cause is not fully understood, but it appears to be related to immune system dysregulation. Triggers include:
-
Infections (respiratory or gastrointestinal)
-
Hematological cancers, such as acute myeloid leukemia
-
Autoimmune or inflammatory diseases
-
Medications (antibiotics, antiepileptics, G-CSF, some vaccines)
Treatment usually involves systemic corticosteroids, which typically provide rapid relief.
Why this case stands out
The most surprising aspect of this case is that Sweet’s syndrome was triggered by an inhaled COPD medication . Until now, no case in the medical literature had linked the condition to inhaled therapies.
Clinical significance
-
Expanding the known triggers : Previously, Sweet’s syndrome was primarily associated with oral or injectable drugs. This case demonstrates that even inhaled medications can trigger rare immune responses.
-
Diagnostic challenges : Due to its rarity, the condition can easily be mistaken for more common skin rashes. Early biopsy is essential.
-
Role of primary care : General practitioners are often the first to detect unusual reactions. Prompt recognition and referral are vital. Lessons for physicians
This case offers several important reminders for healthcare providers:
-
Stay alert after medication changes : even commonly used medications can trigger rare immune reactions.
-
Consider Sweet’s syndrome in cases of sudden, painful skin rashes with fever.
-
Use a broad differential diagnosis : carefully exclude lupus, dermatitis, and drug eruptions.
-
Act quickly with corticosteroids : they remain the most effective treatment.
-
Reporting rare cases : documentation expands medical knowledge and helps future doctors.
Patient’s perspective: Experiencing a rare reaction
For the patient, what began as a standard inhaler change quickly turned into a distressing experience. The painful facial lesions overwhelmed him both physically and emotionally, affecting his self-confidence and social interactions.
Her rapid recovery with corticosteroids was reassuring, but the experience highlighted the anxiety patients face when dealing with rare and little-known diseases. For those with chronic conditions like COPD, trust in their treatment is paramount, making open communication with healthcare professionals especially important.
The broader implications
For the patient, what began as a standard inhaler change quickly turned into a distressing experience. The painful facial lesions overwhelmed him both physically and emotionally, affecting his self-confidence and social interactions.
Her rapid recovery with corticosteroids was reassuring, but the experience highlighted the anxiety patients face when dealing with rare and little-known diseases. For those with chronic conditions like COPD, trust in their treatment is crucial, making open communication with healthcare professionals especially important.
